Zimmer Biomet

Zimmer Biomet is a leading maker of orthopaedic implants and surgical products, specialising in hip and knee replacements alongside a broad range of musculoskeletal devices. An ageing population and rising rates of joint replacement support long-term demand, though the market is competitive and pricing pressure is a persistent headwind. The company reinstated its dividend a few years ago after an earlier suspension, so its record of increases is still relatively short. The yield is low and the payout modest, meaning income is a secondary feature of a stock driven more by its medical-device growth prospects and margin recovery.